These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7790089)

  • 1. Antibody response that protects against disseminated candidiasis.
    Han Y; Cutler JE
    Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.
    Han Y; Morrison RP; Cutler JE
    Infect Immun; 1998 Dec; 66(12):5771-6. PubMed ID: 9826353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.
    Han Y; Kanbe T; Cherniak R; Cutler JE
    Infect Immun; 1997 Oct; 65(10):4100-7. PubMed ID: 9317014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.
    Reiss E; de Repentigny L; Kuykendall RJ; Carter AW; Galindo R; Auger P; Bragg SL; Kaufman L
    J Clin Microbiol; 1986 Nov; 24(5):796-802. PubMed ID: 2429989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.
    Han Y; Riesselman MH; Cutler JE
    Infect Immun; 2000 Mar; 68(3):1649-54. PubMed ID: 10678984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity.
    Caesar-TonThat TC; Cutler JE
    Infect Immun; 1997 Dec; 65(12):5354-7. PubMed ID: 9393840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
    Shukla M; Rohatgi S
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
    Aydın C; Ataoğlu H
    Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
    Tavares D; Ferreira P; Arala-Chaves M
    Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-antigen fusion protein vaccination induces protective immunity against
    Jia K; Zhang Y; Jiang M; Cui M; Wang J; Zhang J; Wang H; Zhao H; Li M; Zou Q; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406065. PubMed ID: 39327639
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
    Xin H; Cutler JE
    Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Xin H
    Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.
    Luo G; Ibrahim AS; French SW; Edwards JE; Fu Y
    PLoS One; 2011; 6(10):e25909. PubMed ID: 22028796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining criteria for anti-mannan antibodies to protect against candidiasis.
    Cutler JE
    Curr Mol Med; 2005 Jun; 5(4):383-92. PubMed ID: 15977994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of fungal extracellular vesicles against murine candidiasis.
    Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L
    Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
    Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
    Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.